Per Oskarsson
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Genetics top 10%
- Diabetes and associated disorders
Papers in
-
- Diabetes Management and Research 10
- Diabetes Treatment and Management 3
- Growth Hormone and Insulin-like Growth Factors 2
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 1
- Genetics 6
- Diabetes and associated disorders 6
- Co-authors
- Jan Bolinder (2 shared papers)Moshe Phillip (1 shared paper)Tadej Battelino (1 shared paper)Nataša Bratina (1 shared paper)Revital Nimri (1 shared paper)Per‐Eric Lins (3 shared papers)P. E. Lins (5 shared papers)Jan‐Gustaf Ljunggren (1 shared paper)
- Journals
- Diabetes Care (2 papers)Diabetic Medicine (2 papers)Diabetes Technology & Therapeutics (1 paper)Diabetes (1 paper)Clinical Endocrinology (1 paper)
- Partner nations
- SwedenUnited KingdomSlovenia
In The Last Decade
Per Oskarsson
14 papers receiving 876 citations
Peers
Comparison fields: 5 of 76
- Endocrinology, Diabetes and Metabolism 644
- Genetics 272
- Surgery 292
- Physiology 103
- Neurology 52
Countries citing papers authored by Per Oskarsson
This map shows the geographic impact of Per Oskarsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Oskarsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Oskarsson more than expected).
Fields of papers citing papers by Per Oskarsson
This network shows the impact of papers produced by Per Oskarsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Oskarsson. The network helps show where Per Oskarsson may publish in the future.
Co-authors
The 25 scholars most cited alongside Per Oskarsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 356 | |
| 2 | 2017 | 128 | |
| 3 | 2008 | 120 | |
| 4 | 1997 | 108 | |
| 5 | 1996 | 89 | |
| 6 | Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients. | 2000 | 33 |
| 7 | 2013 | 22 | |
| 8 | [Adverse drug effect as cause of hospital admission. Common drugs are the major part according to the cross-sectional study]. | 2008 | 20 |
| 9 | Metabolic and hormonal responses to exercise in type 1 diabetic patients during continuous subcutaneous, as compared to continuous intraperitoneal, insulin infusion. | 1999 | 18 |
| 10 | 2003 | 16 | |
| 11 | 2010 | 8 | |
| 12 | 1997 | 5 | |
| 13 | 1999 | 4 | |
| 14 | Intraperitoneal insulin delivery gives higher circulating IGF-I activity than CSII in type 1 diabetes | 2009 | 1 |
| 15 | [Episodes of severe hypoglycemia--increasing problem in type 1 diabetes]. | 2004 | 0 |
About Per Oskarsson
Per Oskarsson is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Surgery, Pharmacology and Toxicology, having authored 15 papers that have together received 928 indexed citations. Recurring topics across this work include Diabetes Management and Research (10 papers), Diabetes and associated disorders (6 papers), Pancreatic function and diabetes (4 papers), Diabetes Treatment and Management (3 papers), Growth Hormone and Insulin-like Growth Factors (2 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper), Pain Mechanisms and Treatments (1 paper) and Pharmacovigilance and Adverse Drug Reactions (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (644 citations), Genetics (272 citations), Surgery (292 citations), Physiology (103 citations) and Neurology (52 citations). Per Oskarsson has collaborated with scholars based in Sweden, United Kingdom and Slovenia. Frequent co-authors include Jan Bolinder, Moshe Phillip, Tadej Battelino, Nataša Bratina, Revital Nimri, Per‐Eric Lins, P. E. Lins, Jan‐Gustaf Ljunggren, Ulf Adamson and Petronella Geelhoed-Duijvestijn. Their work appears in journals such as Diabetes Care, Diabetic Medicine, Diabetes Technology & Therapeutics, Diabetes and Clinical Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.